Source:http://linkedlifedata.com/resource/pubmed/id/20234353
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2010-3-31
|
pubmed:abstractText |
Bone metastases are the most common cause of cancer-related pain. Radiotherapy is a safe and effective therapy and is well established for such a situation. A fractionation regimen with a short overall treatment time (< or =1 week) would be preferred if it was as effective as longer courses (2-4 weeks). Randomized clinical trials and meta-analyses have demonstrated that single-fraction radiotherapy with 1 x 8 Gy is as effective for pain relief as multi-fraction regimens such as 5 x 4 Gy in 1 week or 10 x 3 Gy in 2 weeks. Re-irradiation for recurrent pain in the irradiated region is required more often after single-fraction radiotherapy than multi-fraction radiotherapy; however, re-irradiation following single-fraction radiotherapy is safe and effective. Thus, 1 x 8 Gy is considered the standard regimen for uncomplicated painful bone metastases without pathological fractures or spinal cord compression. Multi-fraction radiotherapy results in significantly better remineralization of the osteolytic bone than single-fraction radiotherapy. Remineralization is important for preventing or treating pathological fractures. Multi-fraction long-course radiotherapy results in fewer recurrences of spinal-cord compression within the irradiated spinal region. Thus, long-course multi-fraction radiotherapy should be reserved for patients with a relatively favorable survival prognosis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1759-4782
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
7
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
220-9
|
pubmed:meshHeading |
pubmed-meshheading:20234353-Bone Neoplasms,
pubmed-meshheading:20234353-Confidence Intervals,
pubmed-meshheading:20234353-Diphosphonates,
pubmed-meshheading:20234353-Dose-Response Relationship, Radiation,
pubmed-meshheading:20234353-Humans,
pubmed-meshheading:20234353-Kyphoplasty,
pubmed-meshheading:20234353-Osteolysis,
pubmed-meshheading:20234353-Pain,
pubmed-meshheading:20234353-Prognosis,
pubmed-meshheading:20234353-Radiotherapy,
pubmed-meshheading:20234353-Risk
|
pubmed:year |
2010
|
pubmed:articleTitle |
Treatment of painful bone metastases.
|
pubmed:affiliation |
Department of Radiation Oncology, University of Lubeck, Ratzeburger Allee 160, 23538 Lubeck, Germany. rades.dirk@gmx.net
|
pubmed:publicationType |
Journal Article,
Review
|